Comments
Loading...
Humana Analyst Ratings and Price Targets | NYSE:HUM | Benzinga
Humana Inc has a consensus price target of $308.26 based on the ratings of 26 analysts. The high is $624 issued by Morgan Stanley on August 30, 2023. The low is $250 issued by Stephens & Co. on October 9, 2024. The 3 most-recent analyst ratings were released by Cantor Fitzgerald, Oppenheimer, and Baird on May 1, 2025, May 1, 2025, and April 15, 2025, respectively. With an average price target of $300 between Cantor Fitzgerald, Oppenheimer, and Baird, there's an implied 15.81% upside for Humana Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Cantor Fitzgerald
Oppenheimer
Baird
Barclays
Truist Securities
1calculated from analyst ratings
Analyst Ratings for Humana
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 05/01/2025 | Buy Now | 11.95% | Cantor Fitzgerald | Sarah James51% | $290 → $290 | Reiterates | Neutral → Neutral | Get Alert |
| 05/01/2025 | Buy Now | 19.67% | Oppenheimer | Michael Wiederhorn20% | $300 → $310 | Maintains | Outperform | Get Alert |
| 04/15/2025 | Buy Now | 15.81% | Baird | Michael Ha60% | $270 → $300 | Maintains | Neutral | Get Alert |
| 04/11/2025 | Buy Now | 24.3% | Barclays | Andrew Mok48% | $270 → $322 | Maintains | Equal-Weight | Get Alert |
| 04/11/2025 | Buy Now | 25.46% | Truist Securities | David Macdonald53% | $290 → $325 | Maintains | Hold | Get Alert |
| 04/09/2025 | Buy Now | 25.84% | Guggenheim | Jason Cassorla49% | → $326 | Initiates | → Buy | Get Alert |
| 04/09/2025 | Buy Now | 21.98% | Mizuho | Ann Hynes85% | $305 → $316 | Maintains | Outperform | Get Alert |
| 02/18/2025 | Buy Now | -1.18% | JP Morgan | Lisa Gill66% | $257 → $256 | Maintains | Neutral | Get Alert |
| 02/13/2025 | Buy Now | 4.23% | Barclays | Andrew Mok48% | $255 → $270 | Maintains | Equal-Weight | Get Alert |
| 02/12/2025 | Buy Now | 9.25% | RBC Capital | Ben Hendrix60% | $283 → $283 | Reiterates | Outperform → Outperform | Get Alert |
| 02/12/2025 | Buy Now | 11.95% | Cantor Fitzgerald | Sarah James51% | $290 → $290 | Reiterates | Neutral → Neutral | Get Alert |
| 02/12/2025 | Buy Now | 10.02% | Morgan Stanley | Erin Wright75% | $301 → $285 | Maintains | Equal-Weight | Get Alert |
| 01/22/2025 | Buy Now | -1.56% | Barclays | Andrew Mok48% | $253 → $255 | Maintains | Equal-Weight | Get Alert |
| 01/15/2025 | Buy Now | 11.18% | Piper Sandler | Jessica Tassan38% | $270 → $288 | Maintains | Neutral | Get Alert |
| 01/06/2025 | Buy Now | 11.95% | Truist Securities | David Macdonald53% | $260 → $290 | Maintains | Hold | Get Alert |
| 12/17/2024 | Buy Now | 16.19% | Morgan Stanley | Erin Wright75% | $288 → $301 | Maintains | Equal-Weight | Get Alert |
| 11/06/2024 | Buy Now | 18.9% | B of A Securities | Kevin Fischbeck70% | $247 → $308 | Upgrade | Underperform → Neutral | Get Alert |
| 11/04/2024 | Buy Now | 3.45% | TD Cowen | Gary Taylor60% | $261 → $268 | Maintains | Hold | Get Alert |
| 11/04/2024 | Buy Now | 11.95% | Wells Fargo | Stephen Baxter54% | $387 → $290 | Maintains | Overweight | Get Alert |
| 10/31/2024 | Buy Now | -2.34% | Barclays | Andrew Mok48% | $250 → $253 | Maintains | Equal-Weight | Get Alert |
| 10/11/2024 | Buy Now | — | Keybanc | Matthew Gillmor65% | — | Initiates | → Sector Weight | Get Alert |
| 10/11/2024 | Buy Now | 0.37% | Truist Securities | David Macdonald53% | $400 → $260 | Maintains | Hold | Get Alert |
| 10/10/2024 | Buy Now | -3.49% | Barclays | Andrew Mok48% | $364 → $250 | Maintains | Equal-Weight | Get Alert |
| 10/09/2024 | Buy Now | -3.49% | Stephens & Co. | Scott Fidel70% | $250 → $250 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 10/08/2024 | Buy Now | 18.9% | Bernstein | Lance Wilkes63% | → $308 | Upgrade | Market Perform → Outperform | Get Alert |
| 10/08/2024 | Buy Now | 2.3% | RBC Capital | Ben Hendrix60% | $400 → $265 | Maintains | Outperform | Get Alert |
| 10/07/2024 | Buy Now | 0.75% | TD Cowen | Gary Taylor60% | $402 → $261 | Downgrade | Buy → Hold | Get Alert |
| 10/07/2024 | Buy Now | -2.34% | Jefferies | David Windley74% | $419 → $253 | Downgrade | Buy → Hold | Get Alert |
| 10/04/2024 | Buy Now | -3.49% | UBS | Kevin Caliendo32% | $380 → $250 | Maintains | Neutral | Get Alert |
| 10/03/2024 | Buy Now | 5.77% | Piper Sandler | Jessica Tassan38% | $392 → $274 | Downgrade | Overweight → Neutral | Get Alert |
| 10/03/2024 | Buy Now | -3.49% | Deutsche Bank | George Hill62% | $349 → $250 | Maintains | Hold | Get Alert |
| 10/03/2024 | Buy Now | 8.09% | Oppenheimer | Michael Wiederhorn20% | $400 → $280 | Maintains | Outperform | Get Alert |
| 10/02/2024 | Buy Now | -4.65% | B of A Securities | Kevin Fischbeck70% | $376 → $247 | Downgrade | Neutral → Underperform | Get Alert |
| 10/02/2024 | Buy Now | -3.49% | Stephens & Co. | Scott Fidel70% | $400 → $250 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 10/02/2024 | Buy Now | -3.49% | Leerink Partners | Whit Mayo63% | $400 → $250 | Downgrade | Outperform → Market Perform | Get Alert |
| 10/01/2024 | Buy Now | 52.48% | Cantor Fitzgerald | Sarah James51% | $395 → $395 | Reiterates | Neutral → Neutral | Get Alert |
| 09/20/2024 | Buy Now | 52.48% | Cantor Fitzgerald | Sarah James51% | $395 → $395 | Reiterates | Neutral → Neutral | Get Alert |
| 09/10/2024 | Buy Now | 52.48% | Cantor Fitzgerald | Sarah James51% | $395 → $395 | Reiterates | Neutral → Neutral | Get Alert |
| 09/05/2024 | Buy Now | 54.41% | RBC Capital | Ben Hendrix60% | $385 → $400 | Maintains | Outperform | Get Alert |
| 08/21/2024 | Buy Now | 52.87% | JP Morgan | Lisa Gill66% | $332 → $396 | Maintains | Neutral | Get Alert |
| 08/19/2024 | Buy Now | 52.48% | Cantor Fitzgerald | Sarah James51% | $395 → $395 | Reiterates | Neutral → Neutral | Get Alert |
| 08/02/2024 | Buy Now | 34.72% | Deutsche Bank | George Hill62% | $341 → $349 | Maintains | Hold | Get Alert |
| 08/01/2024 | Buy Now | 40.51% | Barclays | Andrew Mok48% | $370 → $364 | Maintains | Equal-Weight | Get Alert |
| 08/01/2024 | Buy Now | 54.41% | Oppenheimer | Michael Wiederhorn20% | $370 → $400 | Maintains | Outperform | Get Alert |
| 07/24/2024 | Buy Now | 57.11% | TD Cowen | Gary Taylor60% | $396 → $407 | Maintains | Buy | Get Alert |
| 07/23/2024 | Buy Now | 38.97% | Cantor Fitzgerald | Sarah James51% | $360 → $360 | Reiterates | Neutral → Neutral | Get Alert |
| 07/15/2024 | Buy Now | 54.41% | Truist Securities | David Macdonald53% | $355 → $400 | Maintains | Hold | Get Alert |
| 06/26/2024 | Buy Now | 51.32% | Piper Sandler | Jessica Tassan38% | → $392 | Initiates | → Overweight | Get Alert |
| 06/24/2024 | Buy Now | 44.37% | Morgan Stanley | Erin Wright75% | → $374 | Initiates | → Equal-Weight | Get Alert |
| 06/12/2024 | Buy Now | 38.97% | Cantor Fitzgerald | Sarah James51% | $360 → $360 | Reiterates | Neutral → Neutral | Get Alert |
| 05/30/2024 | Buy Now | 44.37% | Baird | Michael Ha60% | → $374 | Initiates | → Neutral | Get Alert |
| 05/20/2024 | Buy Now | 45.15% | B of A Securities | Kevin Fischbeck70% | $342 → $376 | Maintains | Neutral | Get Alert |
| 04/25/2024 | Buy Now | 36.27% | RBC Capital | Frank Morgan13% | $415 → $353 | Maintains | Outperform | Get Alert |
| 04/25/2024 | Buy Now | 25.84% | UBS | Kevin Caliendo32% | $334 → $326 | Maintains | Neutral | Get Alert |
| 04/25/2024 | Buy Now | 38.97% | Cantor Fitzgerald | Sarah James51% | $391 → $360 | Maintains | Neutral | Get Alert |
| 04/25/2024 | Buy Now | 42.83% | Oppenheimer | Michael Wiederhorn20% | $415 → $370 | Maintains | Outperform | Get Alert |
| 04/22/2024 | Buy Now | 47.08% | Jefferies | David Windley74% | $411 → $381 | Maintains | Buy | Get Alert |
| 04/10/2024 | Buy Now | 50.94% | Cantor Fitzgerald | Sarah James51% | $391 → $391 | Reiterates | Neutral → Neutral | Get Alert |
| 04/08/2024 | Buy Now | 35.11% | Wells Fargo | Stephen Baxter54% | $413 → $350 | Maintains | Overweight | Get Alert |
| 04/04/2024 | Buy Now | 50.94% | Cantor Fitzgerald | Sarah James51% | $391 → $391 | Reiterates | Neutral → Neutral | Get Alert |
| 04/03/2024 | Buy Now | 48.62% | Goldman Sachs | Nathan Rich43% | $450 → $385 | Maintains | Buy | Get Alert |
| 04/02/2024 | Buy Now | 19.67% | Barclays | Andrew Mok48% | $356 → $310 | Maintains | Equal-Weight | Get Alert |
| 04/02/2024 | Buy Now | 52.87% | TD Cowen | Gary Taylor60% | $427 → $396 | Maintains | Buy | Get Alert |
| 04/02/2024 | Buy Now | 32.02% | B of A Securities | Kevin Fischbeck70% | $470 → $342 | Downgrade | Buy → Neutral | Get Alert |
| 03/22/2024 | Buy Now | — | Raymond James | John Ransom75% | — | Initiates | → Market Perform | Get Alert |
| 03/13/2024 | Buy Now | — | Argus Research | David Toung71% | — | Downgrade | Buy → Hold | Get Alert |
| 03/06/2024 | Buy Now | 37.43% | Barclays | Andrew Mok48% | → $356 | Initiates | → Equal-Weight | Get Alert |
| 01/30/2024 | Buy Now | 59.43% | Wells Fargo | Stephen Baxter54% | $465 → $413 | Maintains | Overweight | Get Alert |
| 01/29/2024 | Buy Now | 73.71% | Goldman Sachs | Nathan Rich43% | $515 → $450 | Maintains | Buy | Get Alert |
| 01/26/2024 | Buy Now | 65.99% | Stephens & Co. | Scott Fidel70% | $550 → $430 | Maintains | Overweight | Get Alert |
| 01/26/2024 | Buy Now | 54.41% | Mizuho | Ann Hynes85% | $550 → $400 | Maintains | Buy | Get Alert |
| 01/26/2024 | Buy Now | 50.94% | Cantor Fitzgerald | Sarah James51% | $597 → $391 | Downgrade | Overweight → Neutral | Get Alert |
| 01/26/2024 | Buy Now | 42.83% | UBS | Kevin Caliendo32% | $530 → $370 | Downgrade | Buy → Neutral | Get Alert |
| 01/26/2024 | Buy Now | 60.2% | RBC Capital | Ben Hendrix60% | $507 → $415 | Maintains | Outperform | Get Alert |
| 01/26/2024 | Buy Now | 73.71% | Goldman Sachs | Nathan Rich43% | $515 → $450 | Maintains | Buy | Get Alert |
| 01/25/2024 | Buy Now | 38.97% | Deutsche Bank | George Hill62% | $595 → $360 | Downgrade | Buy → Hold | Get Alert |
| 01/19/2024 | Buy Now | 130.46% | Cantor Fitzgerald | Sarah James51% | $597 → $597 | Reiterates | Overweight → Overweight | Get Alert |
| 01/19/2024 | Buy Now | 112.31% | Truist Securities | David Macdonald53% | → $550 | Reiterates | Hold → Hold | Get Alert |
| 01/19/2024 | Buy Now | 95.72% | RBC Capital | Ben Hendrix60% | $599 → $507 | Maintains | Outperform | Get Alert |
| 01/19/2024 | Buy Now | 98.8% | Goldman Sachs | Nathan Rich43% | $595 → $515 | Maintains | Buy | Get Alert |
| 01/17/2024 | Buy Now | 143.2% | Oppenheimer | Michael Wiederhorn20% | → $630 | Reiterates | Outperform → Outperform | Get Alert |
| 12/12/2023 | Buy Now | 112.31% | Argus Research | David Toung71% | → $550 | Upgrade | Hold → Buy | Get Alert |
| 11/21/2023 | Buy Now | 130.46% | Cantor Fitzgerald | Sarah James51% | → $597 | Reiterates | Overweight → Overweight | Get Alert |
| 11/17/2023 | Buy Now | 121.96% | JP Morgan | Lisa Gill66% | $593 → $575 | Maintains | Neutral | Get Alert |
| 11/02/2023 | Buy Now | 131.23% | RBC Capital | Ben Hendrix60% | $594 → $599 | Maintains | Outperform | Get Alert |
| 11/02/2023 | Buy Now | 120.03% | Stephens & Co. | Scott Fidel70% | $575 → $570 | Maintains | Overweight | Get Alert |
| 11/02/2023 | Buy Now | 130.46% | Cantor Fitzgerald | Sarah James51% | → $597 | Reiterates | Overweight → Overweight | Get Alert |
| 10/09/2023 | Buy Now | 126.21% | Jefferies | David Windley74% | $580 → $586 | Maintains | Buy | Get Alert |
| 09/14/2023 | Buy Now | 130.46% | Cantor Fitzgerald | Sarah James51% | → $597 | Reiterates | Overweight → Overweight | Get Alert |
| 08/30/2023 | Buy Now | 140.88% | Morgan Stanley | Michael Ha60% | $637 → $624 | Maintains | Overweight | Get Alert |
| 08/15/2023 | Buy Now | 136.63% | TD Cowen | Gary Taylor60% | $616 → $613 | Maintains | Outperform | Get Alert |
| 08/08/2023 | Buy Now | 131.23% | Bernstein | Lance Wilkes63% | $568 → $599 | Maintains | Market Perform | Get Alert |
| 08/07/2023 | Buy Now | 142.42% | Deutsche Bank | George Hill62% | $468 → $628 | Maintains | Buy | Get Alert |
| 08/03/2023 | Buy Now | 112.31% | Truist Securities | David Macdonald53% | $530 → $550 | Maintains | Hold | Get Alert |
| 08/03/2023 | Buy Now | 129.3% | RBC Capital | Ben Hendrix60% | $637 → $594 | Maintains | Outperform | Get Alert |
| 08/03/2023 | Buy Now | 116.17% | Stephens & Co. | Scott Fidel70% | $555 → $560 | Maintains | Overweight | Get Alert |
| 07/14/2023 | Buy Now | 145.9% | Morgan Stanley | Michael Ha60% | $637 → $637 | Reiterates | Overweight → Overweight | Get Alert |
| 07/13/2023 | Buy Now | 116.17% | UBS | Kevin Caliendo32% | $620 → $560 | Maintains | Buy | Get Alert |
| 07/13/2023 | Buy Now | 108.84% | Wells Fargo | Stephen Baxter54% | $610 → $541 | Maintains | Overweight | Get Alert |
| 07/11/2023 | Buy Now | 112.31% | Mizuho | Ann Hynes85% | $615 → $550 | Maintains | Buy | Get Alert |
FAQ
What is the target price for Humana (HUM) stock?
The latest price target for Humana (NYSE:HUM) was reported by Cantor Fitzgerald on May 1, 2025. The analyst firm set a price target for $290.00 expecting HUM to rise to within 12 months (a possible 11.95% upside). 52 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Humana (HUM)?
The latest analyst rating for Humana (NYSE:HUM) was provided by Cantor Fitzgerald, and Humana reiterated their neutral rating.
When was the last upgrade for Humana (HUM)?
The last upgrade for Humana Inc happened on November 6, 2024 when B of A Securities raised their price target to $308. B of A Securities previously had an underperform for Humana Inc.
When was the last downgrade for Humana (HUM)?
The last downgrade for Humana Inc happened on October 7, 2024 when TD Cowen changed their price target from $402 to $261 for Humana Inc.
When is the next analyst rating going to be posted or updated for Humana (HUM)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Humana, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Humana was filed on May 1, 2025 so you should expect the next rating to be made available sometime around May 1, 2026.
Is the Analyst Rating Humana (HUM) correct?
While ratings are subjective and will change, the latest Humana (HUM) rating was a reiterated with a price target of $290.00 to $290.00. The current price Humana (HUM) is trading at is $259.05, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
